Source 1primary paper2026MED
Toolkit/RL/FRL-EnE cells
RL/FRL-EnE cells
Also known as: red/far-red light-regulated individually encapsulated cells
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Here, we develop red/far-red light-regulated individually encapsulated (RL/FRL-EnE) cells, integrating optogenetics with biomaterial encapsulation for precise immunomodulation.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Published Workflows
On-demand cancer immunotherapy via single-cell encapsulation of synthetic circuit-engineered cells.
2026Objective: Engineer a light-regulated, tumor-localized cellular immunotherapy platform that enables on-demand and reversible immunomodulator production while reducing systemic toxicity, off-target biodistribution, and host rejection.
Why it works: The abstract states that ΔPhyA-PCB with far-red elongated hypocotyl 1 provides bidirectional red/far-red optical control over immunomodulator expression, while single-cell nanoencapsulation prevents cross-talk and immune clearance to maintain strict light dependence and longer tumor residence.
red/far-red light-controlled heterodimerizationreversible control of cytokine and anti-CD47 expressionsingle-cell encapsulation to prevent intercellular cross-talk and immune clearanceoptogeneticsbiomaterial encapsulation
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Mechanisms
biomaterial single-cell encapsulationHeterodimerizationlight-induced heterodimerizationreversible photoswitchingTechniques
No technique tags yet.
Target processes
recombinationInput: Light
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
This work establishes a paradigm for closed-loop cellular immunotherapy using light-regulated living therapeutics for on-demand immune reprogramming.
In vivo, RL/FRL-EnE cells remodeled the tumor microenvironment by reducing immunosuppressive myeloid cells and increasing dendritic cell and CD8+ T cell infiltration.
CD8 positive T cell infiltration change 2.8 folddendritic cell infiltration change 1.4 foldimmunosuppressive myeloid cells change 1.3- to 1.7-fold reduction
Red light at 660 nm triggers interferon-γ, interleukin-6, and anti-CD47 expression via ΔPhyA-PCB and far-red elongated hypocotyl 1 heterodimerization, while far-red light at 740 nm rapidly reverses production.
far red light wavelength 740 nmred light wavelength 660 nm
Single-cell nanoencapsulation prevents intercellular cross-talk and immune clearance, enabling strict light-dependent regulation and extended tumor residence.
The system uses a phytochrome A-based photoswitch, ΔPhyA-PCB, to enable bidirectional control.
The authors developed red/far-red light-regulated individually encapsulated engineered cells for precise immunomodulation.
Approval Evidence
1 source6 linked approval claimsfirst-pass slug rl-frl-ene-cells
Here, we develop red/far-red light-regulated individually encapsulated (RL/FRL-EnE) cells, integrating optogenetics with biomaterial encapsulation for precise immunomodulation.
Source:
conceptual advancesupports
This work establishes a paradigm for closed-loop cellular immunotherapy using light-regulated living therapeutics for on-demand immune reprogramming.
Source:
in vivo effectsupports
In vivo, RL/FRL-EnE cells remodeled the tumor microenvironment by reducing immunosuppressive myeloid cells and increasing dendritic cell and CD8+ T cell infiltration.
Source:
mechanismsupports
Red light at 660 nm triggers interferon-γ, interleukin-6, and anti-CD47 expression via ΔPhyA-PCB and far-red elongated hypocotyl 1 heterodimerization, while far-red light at 740 nm rapidly reverses production.
Source:
mechanismsupports
Single-cell nanoencapsulation prevents intercellular cross-talk and immune clearance, enabling strict light-dependent regulation and extended tumor residence.
Source:
mechanismsupports
The system uses a phytochrome A-based photoswitch, ΔPhyA-PCB, to enable bidirectional control.
Source:
tool developmentsupports
The authors developed red/far-red light-regulated individually encapsulated engineered cells for precise immunomodulation.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.